Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > unfortunately

<< Previous

Bullboard Posts

Next >>

Comment by Valuehunter72on Jun 18, 2020 1:52am

85 Views

Post# 31163409

RE:unfortunately

Sam 613. You created a new account today just to post that you think the PP is already sold out?

Interesting.

I mean really....why wouldn't it sell out fast?

Just not too fast guys.....
it might look a little too obvious.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec